Revolution Medicines

Revolution Medicines

Associate Director, Revenue Accounting and Finance

Redwood City, California, United States · Director · Full-time

Sponsorship not specified$186k-$233kDetected 1 day ago
ComplianceFinancial AnalysisAccountingForecastingExcelLeadershipCommunicationCollaborationOrganizational SkillsGAAPSarbanes-OxleyFinancial ReportingInternal AuditVariance Analysis

About the role

  • Prepare journal entries, account reconciliations, flux analyses, reserve rollforwards, close schedules, and supporting documentation for revenue and GTN related accounts.
  • Revolution Medicines is seeking a Associate Director, Revenue Accounting and Finance to play a key role in commercial launch readiness as the company prepares for its first product launch and continues its transition to a commercial stage organization.
  • The ideal candidate will bring deep expertise in pharmaceutical revenue and GTN accounting, forecasting, and related financial reporting, along with strong technical accounting judgment and proven experience supporting commercial launch readiness.

Responsibilities

  • Maintain and support robust internal controls over revenue processes, ensuring SOX compliance and audit readiness.
  • Prepare, maintain, and improve RevMed's GTN forecasting models and methodologies for budget, forecast, long range planning, and scenario analysis.
  • Partner directly with the Commercial and Market Access teams to develop and maintain GTN assumptions and forecasts, track performance, and evaluate pricing and contracting strategies.
  • Partner with Analytics & Insights to incorporate relevant demand, patient, and market data into GTN forecasts.
  • Develop dashboards, analytics, and reporting packages that provide visibility into gross sales, discounts, reserve adequacy, forecast accuracy, and emerging risks or opportunities.
  • Drive the adoption of approved AI-enabled tools and automation to eliminate manual processes across revenue accounting, gross-to-net forecasting, account reconciliations, reporting, and month-end close while ensuring compliance with company policies, internal controls, and audit requirements.
  • Collaborate closely with the Senior Director, Revenue Accounting and Finance, and the Vice President, Finance and Corporate Accounting on strategic initiatives, cross functional projects and SEC reporting disclosures.
  • Serve as an HQ partner for global revenue and reporting by coordinating with regional finance and accounting teams to standardize revenue inputs, forecast reporting, variance analysis, key assumptions, controls, and consolidation ready reporting to support senior leadership decision making.

Requirements

  • Minimum of 8+ years of progressive working experience in a similar role within the pharmaceutical or biotechnology industry.

Nice to have

  • CPA or MBA preferred.
  • Bachelor's degree in Accounting, Finance, Economics, or a related field

Skills

  • Bachelor's degree in Accounting, Finance, Economics, or a related field; CPA or MBA preferred.
  • Proactive learner with demonstrated curiosity and interest in using AI.
  • Demonstrated expertise in ASC 606 revenue recognition, gross-to-net (GTN) accounting and forecasting.
  • Experience strengthening accounting processes, and internal controls in compliance with SOX, SEC, and U.S. GAAP requirements.
  • Advanced analytical skills and high proficiency in Microsoft Excel, Word and PowerPoint.
  • Maintain a positive, approachable and professional attitude.
  • Experience supporting global consolidation, regional revenue reporting, intercompany processes.
  • #LI-TS1 #LI-Hybrid
  • The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below.
  • For additional information, please contact privacy@revmed.com.
  • Base Pay Salary Range
  • $186,000 - $233,000 USD

Compensation

  • $186,000 - $233,000 USD
  • Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process.

Benefits

  • Required Skills, Experience and Education:

Company info

  • Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
  • The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
  • The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
  • As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Apply directly at Revolution Medicines →Create a free account for alerts like thisView Revolution Medicines immigration profile

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.